Delivering better treatments
Camurus is committed to improving the lives of patients
with severe and chronic diseases
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care
Interim Report January-March 2023
The interim report January-June is published on 10 May 2023.
Annual General Meeting 2023
The Annual General Meeting in Camurus will be held on Wednesday, 10 May 2023, at 5:00 pm CET at Elite Hotel Ideon in Lund, Sweden.
Lund Spring Symposium
Camurus’ President & CEO Fredrik Tiberg is presenting at this symposium 24-26 May, in Lund, Sweden. The presentation can be seen by the conference participants.
Latest financial report
Camurus Annual Report for 2022
30 March 2023
Diversified pipeline with large potential
Camurus' innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders